The Impact of Value-Based Benefit Design on Adherence to Diabetes Medications: A Propensity Score-Weighted Difference in Difference Evaluation

Author： Zeng Feng   An Jae Jin   Scully Robert   Barrington Christina   Patel Bimal V.   Nichol Michael B.  

Publisher： Blackwell Publishing

ISSN： 1098-3015

Source： Value in Health, Vol.13, Iss.6, 2010-09, pp. : 846-852

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Analysis of the prognostic value of BMI and the difference in its impact according to age and sex in DLBCL patients

By  

Hematological Oncology (Electronic), Vol. 36, Iss. 1, 2018-02 ,pp. : 76-83

John Wiley & Sons Inc

Access to resources Recommend Favorite

Value-Based Pricing: Incentive for Innovation or Zero Net Benefit?

By Hughes Dyfrig A.  

PharmacoEconomics, Vol. 29, Iss. 9, 2011-09 ,pp. : 731-735

Adis International

Access to resources Recommend Favorite

Value-based pricing hot at ISPOR

By  

PharmacoEconomics and Outcomes News, Vol. 1, Iss. 642, 2011-01 ,pp. : 5-6

Adis International

Access to resources Recommend Favorite

Diabetes abolishes the gender difference in vasopressin-mediated potentiation of sympathetic vasoconstriction

By Sanz E.   Monge L.   Fernandez N.   Martnez M.A.   Dieguez G.   Garca-Villalon A.L.  

European Journal of Pharmacology, Vol. 427, Iss. 3, 2001-09 ,pp. : 243-250

Elsevier

Access to resources Recommend Favorite

Hepatic arterial infusion chemotherapy with cisplatin and sorafenib in hepatocellular carcinoma patients unresponsive to transarterial chemoembolization: A propensity score‐based weighting

By  

Journal of Digestive Diseases, Vol. 16, Iss. 3, 2015-03 ,pp. : 143-151

John Wiley & Sons Inc

Access to resources Recommend Favorite